Literature DB >> 10706721

The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages.

M C Bosco1, A Rapisarda, S Massazza, G Melillo, H Young, L Varesio.   

Abstract

We previously found that the tryptophan catabolite picolinic acid (PA) is a costimulus for the activation of macrophage effector functions. In this study, we have investigated the ability of PA to modulate the expression of chemokines in macrophages. We demonstrate that PA is a potent activator of the inflammatory chemokines MIP (macrophage inflammatory protein)-1 alpha and MIP-1 beta (MIPs) mRNA expression in mouse macrophages in a dose- and time-dependent fashion and through a de novo protein synthesis-dependent process. The induction by PA occurred within 3 h of treatment and reached a peak in 12 h. The stimulatory effects of PA were selective for MIPs because other chemokines, including monocyte chemoattractant protein-1, RANTES, IFN-gamma-inducible protein-10, MIP-2, and macrophage-derived chemokine, were not induced under the same experimental conditions and were not an epiphenomenon of macrophage activation because IFN-gamma did not affect MIPs expression. Induction of both MIP-1 alpha and MIP-1 beta by PA was associated with transcriptional activation and mRNA stabilization, suggesting a dual molecular mechanism of control. Iron chelation could be involved in MIPs induction by PA because iron sulfate inhibited the process and the iron-chelating agent, desferrioxamine, induced MIPs expression. We propose the existence of a new pathway leading to inflammation initiated by tryptophan catabolism that can communicate with the immune system through the production of PA, followed by secretion of chemokines by macrophages. These results establish the importance of PA as an activator of macrophage proinflammatory functions, providing the first evidence that this molecule can be biologically active without the need for a costimulatory agent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706721     DOI: 10.4049/jimmunol.164.6.3283

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase.

Authors:  Atsushi Tanabe; Yukari Egashira; Shin-Ichi Fukuoka; Katsumi Shibata; Hiroo Sanada
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

2.  Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; Heidi Ormstad; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

3.  Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition.

Authors:  Catherine J Clark; Gillian M Mackay; George A Smythe; Sonia Bustamante; Trevor W Stone; R Stephen Phillips
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Kynurenine pathway metabolites in humans: disease and healthy States.

Authors:  Yiquan Chen; Gilles J Guillemin
Journal:  Int J Tryptophan Res       Date:  2009-01-08

5.  Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Supaksorn Thika; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Cristiano Noto; Rada Ivanova; Michael Maes
Journal:  Metab Brain Dis       Date:  2017-03-03       Impact factor: 3.584

Review 6.  The involvement of astrocytes and kynurenine pathway in Alzheimer's disease.

Authors:  Ka Ka Ting; Bruce Brew; Gilles Guillemin
Journal:  Neurotox Res       Date:  2007-12       Impact factor: 3.911

7.  NADPH oxidase limits lipopolysaccharide-induced lung inflammation and injury in mice through reduction-oxidation regulation of NF-κB activity.

Authors:  Wei Han; Hui Li; Jiyang Cai; Linda A Gleaves; Vasiliy V Polosukhin; Brahm H Segal; Fiona E Yull; Timothy S Blackwell
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

8.  The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.

Authors:  Yiquan Chen; Roger Stankovic; Karen M Cullen; Vincent Meininger; Brett Garner; Sarah Coggan; Ross Grant; Bruce J Brew; Gilles J Guillemin
Journal:  Neurotox Res       Date:  2009-11-18       Impact factor: 3.911

Review 9.  The Kynurenine Pathway in the Acute and Chronic Phases of Cerebral Ischemia.

Authors:  María Isabel Cuartero; Juan de la Parra; Alicia García-Culebras; Iván Ballesteros; Ignacio Lizasoain; María Ángeles Moro
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

10.  Production of L-tryptophan-derived catabolites in hepatocytes from streptozotocin-induced diabetic rats.

Authors:  Naho Sasaki; Yukari Egashira; Hiroo Sanada
Journal:  Eur J Nutr       Date:  2009-01-23       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.